Accenture is trading at $192.09 (+4.45%), with no confirmed company-specific catalyst explaining the September 14 gain.
- Wells Fargo downgraded Accenture to Equal Weight from Overweight, retaining a $194 price target; shares had risen 2.8% premarket.
- The downgrade does not directly explain the advance, and broader technology stocks are declining, leaving the move’s cause unclear.
- Accenture remains volatile after recent earnings and guidance concerns, but those events were not released on September 14.